PMID- 37366328 OWN - NLM STAT- MEDLINE DCOM- 20230628 LR - 20230809 IS - 1468-2834 (Electronic) IS - 0002-0729 (Print) IS - 0002-0729 (Linking) VI - 52 IP - 6 DP - 2023 Jun 1 TI - Trends in the use of psychotropics in older people with dementia: interrupted time series of Finnish clinical guidelines of behavioural and psychological symptoms of dementia. LID - 10.1093/ageing/afad094 [doi] LID - afad094 AB - BACKGROUND: Up to 90% of people with dementia experience behavioural and psychological symptoms of dementia (BPSD) as part of their illness. Psychotropics are not recommended as the first-line treatment of BPSD because older people are more prone to adverse reactions. In this study, we evaluate the impact of the Finnish clinical guidelines of BPSD (published in 2017) on psychotropic use in people with dementia. METHODS: This study is based on Finnish Prescription Register data from 2009 to 2020. The data included all community-dwelling Finnish people aged >/=65 and who had anti-dementia medication purchases (n = 217,778). We used three-phased interrupted time series design to evaluate the changes in levels and trends of monthly (n = 144) psychotropic user rates compared with the predicted trends. In addition, we evaluated the changes in levels and trends of monthly new psychotropic user rates. RESULTS: The level of monthly psychotropic user rate decreased non-significantly during the intervention period (beta -0.057, P = 0.853), and during the post-intervention period, there was an increase in the level (beta 0.443, P = 0.091) and slope (beta 0.199, P = 0.198), but not statistically significant. The level of monthly new psychotropic user rate (beta -0.009, P = 0.949) during the intervention period and the level (beta 0.044, P = 0.714) and slope (beta 0.021, P = 0.705) during the post-intervention period were almost unchanged. CONCLUSIONS: Results may indicate possible challenges in deprescribing and better adherence to the guidelines at the beginning of BPSD treatment. Further research into the barriers to implement BPSD guidelines and the availability of non-pharmacological treatments is needed. CI - (c) The Author(s) 2023. Published by Oxford University Press on behalf of the British Geriatrics Society. FAU - Rantsi, Mervi AU - Rantsi M AUID- ORCID: 0000-0002-0974-4474 AD - Department of Health and Social Management, University of Eastern Finland, Kuopio, Finland. FAU - Kortelainen, Lauri AU - Kortelainen L AD - Department of Health and Social Management, University of Eastern Finland, Kuopio, Finland. FAU - Hyttinen, Virva AU - Hyttinen V AD - Department of Health and Social Management, University of Eastern Finland, Kuopio, Finland. FAU - Jyrkka, Johanna AU - Jyrkka J AD - Information and Development Services Unit, Finnish Medicines Agency, Helsinki, Finland. FAU - Kankaanpaa, Eila AU - Kankaanpaa E AD - Department of Health and Social Management, University of Eastern Finland, Kuopio, Finland. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Age Ageing JT - Age and ageing JID - 0375655 RN - 0 (Psychotropic Drugs) SB - IM MH - Humans MH - Aged MH - Finland/epidemiology MH - Interrupted Time Series Analysis MH - *Psychotropic Drugs/adverse effects MH - *Mental Disorders/drug therapy PMC - PMC10294559 OTO - NOTNLM OT - behavioural and psychological symptoms of dementia OT - clinical guidelines OT - impact OT - interrupted time series OT - older people OT - psychotropics COIS- None. EDAT- 2023/06/27 13:10 MHDA- 2023/06/28 06:43 PMCR- 2023/06/26 CRDT- 2023/06/27 07:42 PHST- 2022/11/04 00:00 [received] PHST- 2023/03/15 00:00 [revised] PHST- 2023/06/28 06:43 [medline] PHST- 2023/06/27 13:10 [pubmed] PHST- 2023/06/27 07:42 [entrez] PHST- 2023/06/26 00:00 [pmc-release] AID - 7207834 [pii] AID - afad094 [pii] AID - 10.1093/ageing/afad094 [doi] PST - ppublish SO - Age Ageing. 2023 Jun 1;52(6):afad094. doi: 10.1093/ageing/afad094.